TY  - GEN
AU  - Elam,Marshall B
AU  - Ginsberg,Henry N
AU  - Lovato,Laura C
AU  - Corson,Marshall
AU  - Largay,Joseph
AU  - Leiter,Lawrence A
AU  - Lopez,Carlos
AU  - O'Connor,Patrick J
AU  - Sweeney,Mary Ellen
AU  - Weiss,Daniel
AU  - Friedewald,William T
AU  - Buse,John B
AU  - Gerstein,Hertzel C
AU  - Probstfield,Jeffrey
AU  - Grimm,Richard
AU  - Ismail-Beigi,Faramarz
AU  - Goff,David C
AU  - Fleg,Jerome L
AU  - Rosenberg,Yves
AU  - Byington,Robert P
TI  - Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes
SN  - 2380-6591
PY  - 2019///0530
KW  - Aged
KW  - Biomarkers
KW  - blood
KW  - Cardiovascular Diseases
KW  - Diabetes Mellitus, Type 2
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Drug Therapy, Combination
KW  - Dyslipidemias
KW  - Female
KW  - Fenofibrate
KW  - therapeutic use
KW  - Follow-Up Studies
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - Hypolipidemic Agents
KW  - Lipids
KW  - Male
KW  - Middle Aged
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1001/jamacardio.2016.4828
ER  -